Novo Nordisk

Novo Nordisk

Novo Nordisk

We are committed to #changingdiabetes & possibilities in #haemophilia. Sharing stories & updates from around the world. Disclaimer on our site
Founded
1923
Follow us
Alexa global traffic share
Twitter followers
Team Size
10000+
Employees
Location
Headquarters
FinSMEs

Novo Nordisk to Buy Corvidia Therapeutics, for Up To $2.1 Billion

Crunchbase News

Novo Nordisk To Buy Corvidia Therapeutics For Up To $2.1B

Xconomy

Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia

Bloomberg Technology

Novo Nordisk Joins Other Drugmakers With Gains on Virus Stockpiling

Xconomy

Novo Nordisk Pauses 3 Clinical Trials Testing Hemophilia Therapy

Xconomy

Looking to Level Up in NASH, Novo Nordisk Licenses Ube Drug Candidate

Reuters Top News

Novo Nordisk targets bigger slice of diabetes market with new tablet

Reuters Top News

Novo Nordisk to cut insulin prices in the U.S.

Reuters Top News

Denmark's Novo Nordisk files lawsuit against Mylan over patent

Reuters Top News

Novo Nordisk profit tops forecast as new diabetes drug shines

MedCity News

Taiwanese startup Health2Sync inks Novo Nordisk deal to drive growth in Japan

GeekWire

Novo Nordisk teaming up with startups for diabetes challenge, aiming to create new digital health tools

Xconomy

Eli Lilly Strikes Deal for Diabetes Pill to Gain on Novo Nordisk

Bloomberg

Novo Nordisk Is on High But Shaky Ground

Health Earnings
Bloomberg

Novo Nordisk's Deal Discipline Is Behind the Times

Health Stock markets
Bloomberg

Novo Goes Public With $3.1 Billion Bid to Pressure Ablynx

Health Strategy
Xconomy

Novo Nordisk Diabetes Drug Beats Lilly’s Trulicity in Head-to-Head Test

Health Earnings
The Motley Fool

What Is It About Novo Nordisk's Diabetes Drug That Makes It a Top Seller?

Health
The Motley Fool

5 Companies We'd Buy and Hold for the Next 20 Years

Earnings Stock markets
The Motley Fool

Novo Nordisk A/S Injecting Future Sales